U.S. flag

An official website of the United States government

NM_003002.4(SDHD):c.34G>A (p.Gly12Ser) AND Paragangliomas 1

Germline classification:
Benign (3 submissions)
Last evaluated:
Jun 9, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000007300.20

Allele description [Variation Report for NM_003002.4(SDHD):c.34G>A (p.Gly12Ser)]

NM_003002.4(SDHD):c.34G>A (p.Gly12Ser)

Genes:
LOC126861339:BRD4-independent group 4 enhancer GRCh37_chr11:111957035-111958234 [Gene]
SDHD:succinate dehydrogenase complex subunit D [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q23.1
Genomic location:
Preferred name:
NM_003002.4(SDHD):c.34G>A (p.Gly12Ser)
Other names:
SDHD, GLY12SER (rs34677591)
HGVS:
  • NC_000011.10:g.112086941G>A
  • NG_012337.3:g.5095G>A
  • NG_033145.1:g.4858C>T
  • NM_001276503.2:c.34G>A
  • NM_001276504.2:c.34G>A
  • NM_001276506.2:c.34G>A
  • NM_003002.3(SDHD):c.34G>A
  • NM_003002.4:c.34G>AMANE SELECT
  • NP_001263432.1:p.Gly12Ser
  • NP_001263433.1:p.Gly12Ser
  • NP_001263435.1:p.Gly12Ser
  • NP_002993.1:p.Gly12Ser
  • LRG_9t1:c.34G>A
  • LRG_9:g.5095G>A
  • LRG_9p1:p.Gly12Ser
  • NC_000011.9:g.111957665G>A
  • NM_001276506.1:c.34G>A
  • NM_003002.2:c.34G>A
  • NM_003002.3(SDHD):c.34G>A
  • NM_003002.3:c.34G>A
  • NM_003002.4:c.34G>A
  • NR_077060.2:n.69G>A
  • O14521:p.Gly12Ser
  • p.G12S
Protein change:
G12S; GLY12SER
Links:
UniProtKB: O14521#VAR_017870; OMIM: 602690.0011; dbSNP: rs34677591
NCBI 1000 Genomes Browser:
rs34677591
Molecular consequence:
  • NM_001276503.2:c.34G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276504.2:c.34G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276506.2:c.34G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003002.4:c.34G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_077060.2:n.69G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Paragangliomas 1
Synonyms:
Paragangliomata; Glomus tumors familial 1; Paraganglioma - glomus jugulare; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008192; MedGen: C3494181; Orphanet: 29072; OMIM: 168000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000297096Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
criteria provided, single submitter

(DGD Variant Analysis Guidelines)
Benign
(Nov 6, 2015)
unknownclinical testing

DGD_Variant_Analysis_Guidelines.docx,

Citation Link,

SCV002054698Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Jul 15, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004362298Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Jun 9, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia, SCV000297096.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV002054698.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV004362298.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024